You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 82 No. 5, November 1969 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Effects of Chronic Cholinesterase Inhibitor Treatment

I: The Pharmacological and Physiological Behavior of the Anti-ChE-Treated Monkey (Macaca mulatta) Iris

Laszlo Z. Bito, PhD; Nelson Banks, MD

Arch Ophthalmol. 1969;82(5):681-686.


Abstract

In spite of continued daily or twice daily topical anticholinesterase (ChE) application (isoflurophate [diisopropyl fluorophosphate] or echothiophate iodide), the pupils of monkey eyes redilate to near normal size by the fifth day of the chronic cholinesterase inhibitor treatment. The light reflexes appear to be unaffected even after weeks of isoflurophate treatment, but the irides of these eyes become unreactive to normal doses of pilocarpine hydrochloride or carbachol. There was no evidence that topically applied pilocarpine interferes with the light reaction in either the normal or the anti-ChE-pretreated monkey eye. After termination of the chronic isoflurophate treatment the pilocarpine insensitivity is maintained for at least three days, and normal sensitivity to pilocarpine does not completely return within seven days of the last isoflurophate treatment.



Author Affiliations

New York

From the Department of Ophthalmology Research, College of Physicians and Surgeons, Columbia University, New York.


Footnotes

Submitted for publication March 17, 1969.

A preliminary report was read before the spring 1968 National Meeting of the Association for Research in Ophthalmology, Tampa, Fla, April 29-May 1, 1968.

Reprint requests to 630 W 168th St, New York 10032 (Dr. Bito).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Is Phenylephrine Pivalate a Prodrug?
Mindel et al.
Arch Ophthalmol 1980;98:2220-2223.
ABSTRACT  

Effects of Echothiophate on Cholinesterases in Cat Irides
Harris et al.
Arch Ophthalmol 1974;91:57-59.
ABSTRACT  

Dose-Response Analysis of Echothiophate Iodide
Harris
Arch Ophthalmol 1971;86:502-505.
ABSTRACT  

Pharmacology and Toxicology of Ophthalmic Drugs
Macri
Arch Ophthalmol 1970;84:532-545.
 





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1969 American Medical Association. All Rights Reserved.